Derek Weycker

10.1k total citations · 2 hit papers
170 papers, 7.2k citations indexed

About

Derek Weycker is a scholar working on Epidemiology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Derek Weycker has authored 170 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 52 papers in Oncology and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Derek Weycker's work include Neutropenia and Cancer Infections (39 papers), Pneumonia and Respiratory Infections (34 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers). Derek Weycker is often cited by papers focused on Neutropenia and Cancer Infections (39 papers), Pneumonia and Respiratory Infections (34 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (28 papers). Derek Weycker collaborates with scholars based in United States, United Kingdom and Switzerland. Derek Weycker's co-authors include John Edelsberg, Gerry Oster, Williamson Z. Bradford, Ganesh Raghu, Alex Kartashov, Paul W. Noble, Talmadge E. King, Ulrich Costabel, Roland M. du Bois and Rich Barron and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Derek Weycker

158 papers receiving 7.0k citations

Hit Papers

Incidence and Prevalence ... 2006 2026 2012 2019 2006 2011 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Derek Weycker 3.8k 1.7k 1.3k 1.1k 640 170 7.2k
Kevin C. Abbott 1.7k 0.5× 1.8k 1.1× 1.0k 0.8× 436 0.4× 2.4k 3.7× 216 9.4k
Kari Bohlke 907 0.2× 1.0k 0.6× 2.6k 2.0× 1.2k 1.0× 1.8k 2.9× 70 9.2k
Yu‐Xiao Yang 1.6k 0.4× 2.1k 1.3× 2.3k 1.7× 403 0.4× 3.7k 5.8× 208 8.8k
Callum G. Fraser 1.6k 0.4× 752 0.5× 2.6k 1.9× 2.5k 2.2× 1.6k 2.5× 232 7.4k
Julio Pascual 1.1k 0.3× 1.3k 0.8× 930 0.7× 333 0.3× 2.8k 4.3× 319 9.3k
Françoise Roudot‐Thoraval 1.9k 0.5× 4.4k 2.7× 558 0.4× 493 0.4× 1.8k 2.8× 239 10.7k
Nils Milman 1.9k 0.5× 691 0.4× 440 0.3× 1.4k 1.2× 1.0k 1.6× 303 8.3k
Tak Mao Chan 1.3k 0.4× 2.2k 1.3× 958 0.7× 421 0.4× 1.5k 2.3× 442 13.2k
Hartmut Bertz 556 0.1× 895 0.5× 2.2k 1.6× 1.2k 1.0× 687 1.1× 210 7.0k
Aasma Shaukat 3.1k 0.8× 731 0.4× 4.2k 3.1× 261 0.2× 2.1k 3.3× 196 6.9k

Countries citing papers authored by Derek Weycker

Since Specialization
Citations

This map shows the geographic impact of Derek Weycker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Weycker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Weycker more than expected).

Fields of papers citing papers by Derek Weycker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Weycker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Weycker. The network helps show where Derek Weycker may publish in the future.

Co-authorship network of co-authors of Derek Weycker

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Weycker. A scholar is included among the top collaborators of Derek Weycker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Weycker. Derek Weycker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kessler, Asia Sikora, et al.. (2025). Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice. Journal of clinical lipidology. 19(3). e119–e120. 1 indexed citations
3.
Kessler, Asia Sikora, et al.. (2025). Rates of acute pancreatitis and cardiovascular events among adults with severe or extreme hypertriglyceridemia in US clinical practice. Lipids in Health and Disease. 24(1). 252–252. 1 indexed citations
4.
Weycker, Derek, Rotem Lapidot, Mark H. Rozenbaum, et al.. (2025). Cost of invasive pneumococcal disease, all-cause pneumonia, and all-cause otitis media among commercial-insured US children. Journal of Medical Economics. 28(1). 517–523.
6.
Weycker, Derek, et al.. (2024). DRUG PATTERNS, CLINICAL OUTCOMES, AND ECONOMIC COSTS AMONG HEREDITARY ANGIOEDEMA PATIENTS INITIATING LONG-TERM PROPHYLAXIS. Annals of Allergy Asthma & Immunology. 133(6). S26–S26.
8.
Mendes, Diana, Mark Atwood, Reiko Sato, et al.. (2023). OP78 Cost-effectiveness Of A 20-valent Pneumococcal Conjugate Vaccine To Directly Protect Adults Against Pneumococcal Disease In England. International Journal of Technology Assessment in Health Care. 39(S1). S20–S21.
9.
Kreuter, Michael, Joyce Lee, Argyrios Tzouvelekis, et al.. (2021). Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 204(1). 74–81. 106 indexed citations
10.
11.
Weycker, Derek, Hongsheng Wu, Anjali Sharma, et al.. (2019). Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. Journal of Medical Economics. 23(2). 184–192. 30 indexed citations
12.
Weycker, Derek, Xiaoyan Li, Gail Wygant, et al.. (2018). SAFETY AND EFFECTIVENESS OF APIXABAN VERSUS WARFARIN IN THE TREATMENT AND PREVENTION OF VENOUS THROMBOEMBOLISM. Journal of the American College of Cardiology. 71(11). A1953–A1953. 1 indexed citations
13.
Weycker, Derek, Gary L. Hansen, & Frederic D. Seifer. (2017). Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chronic Respiratory Disease. 14(4). 377–384. 125 indexed citations
14.
Delea, Thomas E., Derek Weycker, Mark Atwood, et al.. (2017). Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada. PLoS ONE. 12(5). e0175721–e0175721. 13 indexed citations
15.
Kreuter, Michael, Paolo Spagnolo, Wim Wuyts, et al.. (2016). S98 Antacid therapy and disease progression in patients with idiopathic pulmonary fibrosis (IPF) under pirfenidone treatment. Thorax. 71(Suppl 3). A58.1–A58.
16.
Kreuter, Michael, Marlies Wijsenbeek, Martina Vašáková, et al.. (2016). Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis. European Respiratory Journal. 47(6). 1776–1784. 42 indexed citations
18.
Bois, Roland M. du, Derek Weycker, Carlo Albera, et al.. (2010). Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important Difference. American Journal of Respiratory and Critical Care Medicine. 183(9). 1231–1237. 330 indexed citations
19.
Weycker, Derek, John Edelsberg, Gerry Oster, & Gregory Tino. (2005). ASSOCIATION BETWEEN RISK OF ACUTE EXACERBATIONS AND AGE IN PATIENTS WITH BRONCHIECTASIS. CHEST Journal. 128(4). 153S–153S. 1 indexed citations
20.
Weycker, Derek. (1998). Predicting physicians' medical malpractice experience. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026